The goal associated with these stated primary objectives is that """"""""important and novel research issues can be addressed which would not be possible with the resources available at any one center"""""""" and that these research activities, using the resources of the data coordination center, """"""""may be supported through the usual NIH and other federal and non-federal sources for funding investigator initiated applications"""""""". We have re-structured the stated objectives into Specific Aims for our proposed Alzheimer's Disease Data Coordinating Center: 1. To migrate, continue data flow, and maintain the existing Minimum Data Set (MDS) providing means of access to the centers, security and data quality control; 2. To use the MDS data to establish an auxiliary database which catalogs tissues and biological specimens available at participating ADCs; to describe numbers and types of specimens available and facilitate contact between investigators while maintaining data security and confidentiality; 3. To provide statistical and epidemiologic consulting concerning research questions, study designs, and analytic methods best suited to the MDS and the biologic specimen database; 4. To foster collaborative research among ADCs for research questions best addressed by """"""""expanded"""""""" data collection: to insure rigorous design/analysis standards for feasibility studies; to provide a mechanism for review and funding of Feasibility studies through the ADDCC in conjunction with the Steering Committee to require a hypothesis-driven approach to """"""""expanded"""""""", retrospective and prospective data collection; to formulate designs and analyses for important or novel research questions, as determined by the Steering Committee in conjunction with the ADC directors; 5. To participate in the expansion of successful feasibility studies toward ADC-wide (or consortium) initiatives which would be funded by other means; to provide consultation on the design and analysis of those studies to provide, as needed and as feasible, the 'core' statistical and database functions for those studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AG016976-04
Application #
6509658
Study Section
Special Emphasis Panel (ZAG1-DAG-1 (M1))
Program Officer
Phelps, Creighton H
Project Start
1999-07-01
Project End
2004-06-30
Budget Start
2002-07-15
Budget End
2003-06-30
Support Year
4
Fiscal Year
2002
Total Cost
$3,136,461
Indirect Cost
Name
University of Washington
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Wang, Tingyan; Qiu, Robin G; Yu, Ming (2018) Predictive Modeling of the Progression of Alzheimer's Disease with Recurrent Neural Networks. Sci Rep 8:9161
Wilmoth, Kristin; LoBue, Christian; Clem, Matthew A et al. (2018) Consistency of traumatic brain injury reporting in older adults with and without cognitive impairment. Clin Neuropsychol 32:524-529
Burke, Shanna L; Hu, Tianyan; Spadola, Christine E et al. (2018) Treatment of Sleep Disturbance May Reduce the Risk of Future Probable Alzheimer's Disease. J Aging Health :898264318795567
Brainstorm Consortium (see original citation for additional authors) (2018) Analysis of shared heritability in common disorders of the brain. Science 360:
Ting, Simon Kang Seng; Foo, Heidi; Chia, Pei Shi et al. (2018) Dyslexic Characteristics of Chinese-Speaking Semantic Variant of Primary Progressive Aphasia. J Neuropsychiatry Clin Neurosci 30:31-37
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Kunutsor, Setor K; Laukkanen, Jari A; Burgess, Stephen (2018) Genetically elevated gamma-glutamyltransferase and Alzheimer's disease. Exp Gerontol 106:61-66
Kamara, Dennis M; Gangishetti, Umesh; Gearing, Marla et al. (2018) Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease. J Alzheimers Dis 62:1815-1826
Khachaturian, Ara S; Hayden, Kathleen M; Mielke, Michelle M et al. (2018) Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework. Alzheimers Dement 14:532-534
Davis, Matthew; O Connell, Thomas; Johnson, Scott et al. (2018) Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia. Curr Alzheimer Res 15:777-788

Showing the most recent 10 out of 552 publications